ArticleCurrent protocols2024

Efficient CRISPR/Cas9 Knock-in Approaches for Manipulation of Endogenous Genes in Human B Lymphoma Cells.

Laura A Murray-Nerger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.